Editas Medicine, Inc.
EDIT
$2.80
-$0.035-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.90M | 35.84M | 32.31M | 61.76M | 67.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.90M | 35.84M | 32.31M | 61.76M | 67.03M |
| Cost of Revenue | 139.02M | 177.05M | 199.25M | 220.19M | 213.07M |
| Gross Profit | -100.12M | -141.22M | -166.93M | -158.43M | -146.03M |
| SG&A Expenses | 60.68M | 66.02M | 71.99M | 70.09M | 66.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 199.70M | 243.08M | 271.23M | 290.28M | 280.05M |
| Operating Income | -160.80M | -207.24M | -238.92M | -228.52M | -213.02M |
| Income Before Tax | -236.86M | -251.23M | -237.09M | -210.57M | -193.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -236.86 | -251.23 | -237.09 | -210.57 | -193.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -236.86M | -251.23M | -237.09M | -210.57M | -193.45M |
| EBIT | -160.80M | -207.24M | -238.92M | -228.52M | -213.02M |
| EBITDA | -154.07M | -200.92M | -233.11M | -222.63M | -207.21M |
| EPS Basic | -2.85 | -3.04 | -2.88 | -2.56 | -2.36 |
| Normalized Basic EPS | -1.19 | -1.50 | -1.71 | -1.59 | -1.46 |
| EPS Diluted | -2.85 | -3.04 | -2.88 | -2.56 | -2.36 |
| Normalized Diluted EPS | -1.19 | -1.50 | -1.71 | -1.59 | -1.46 |
| Average Basic Shares Outstanding | 332.57M | 330.46M | 329.35M | 328.44M | 327.61M |
| Average Diluted Shares Outstanding | 332.57M | 330.46M | 329.35M | 328.44M | 327.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |